Pages that link to "Q36173107"
Jump to navigation
Jump to search
The following pages link to A comprehensive listing of bioactivation pathways of organic functional groups (Q36173107):
Displaying 50 items.
- The reactive metabolite target protein database (TPDB)--a web-accessible resource (Q21284213) (← links)
- Role of reactive metabolites in the circulation in extrahepatic toxicity (Q26849288) (← links)
- Novel in vitro and mathematical models for the prediction of chemical toxicity (Q26851492) (← links)
- Reactive metabolites in the biotransformation of molecules containing a furan ring (Q26860879) (← links)
- Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors (Q27664544) (← links)
- Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries (Q27902347) (← links)
- Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects (Q28468284) (← links)
- Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future (Q28468289) (← links)
- The ChEMBL database in 2017 (Q28584450) (← links)
- Creating a hyperpolarised pseudo singlet state through polarisation transfer from parahydrogen under SABRE (Q28817268) (← links)
- Site-specific arylation of rat glutathione s-transferase A1 and A2 by bromobenzene metabolites in vivo (Q28909763) (← links)
- Analytical tools and approaches for metabolite identification in early drug discovery (Q30011018) (← links)
- High-throughput metabolic stability studies in drug discovery by orthogonal acceleration time-of-flight (OATOF) with analogue-to-digital signal capture (ADC). (Q30484521) (← links)
- An informatic pipeline for managing high-throughput screening experiments and analyzing data from stereochemically diverse libraries (Q30616554) (← links)
- Proposal of an in silico profiler for categorisation of repeat dose toxicity data of hair dyes (Q30828343) (← links)
- Post-acquisition analysis of untargeted accurate mass quadrupole time-of-flight MS(E) data for multiple collision-induced neutral losses and fragment ions of glutathione conjugates. (Q30868425) (← links)
- Relationship between structural alerts in NSAIDs and idiosyncratic hepatotoxicity: an analysis of spontaneous report data from the WHO database (Q30912283) (← links)
- How to report and discuss ADME data in medicinal chemistry publications: in vitro data or in vivo extrapolations? (Q30920065) (← links)
- Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist (Q33598627) (← links)
- Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators (Q33636024) (← links)
- Bioactivation of Isothiazoles: Minimizing the Risk of Potential Toxicity in Drug Discovery (Q33687565) (← links)
- The role of toxicoproteomics in assessing organ specific toxicity (Q33786700) (← links)
- Strategies for discovering and derisking covalent, irreversible enzyme inhibitors (Q34023143) (← links)
- An investigation into pharmaceutically relevant mutagenicity data and the influence on Ames predictive potential (Q34080242) (← links)
- Constituents in Kava Extracts Potentially Involved in Hepatotoxicity: A Review (Q34179570) (← links)
- Strategies for the generation, validation and application of in silico ADMET models in lead generation and optimization. (Q34360291) (← links)
- Lessons from a BACE1 inhibitor trial: off-site but not off base. (Q34381433) (← links)
- ω-Conotoxin GVIA mimetics that bind and inhibit neuronal Ca(v)2.2 ion channels (Q34483999) (← links)
- FAF-Drugs3: a web server for compound property calculation and chemical library design. (Q35604907) (← links)
- Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI)-Mediated Lipid Transport (Q35811972) (← links)
- Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib (Q36409174) (← links)
- Cytochrome P450s and other enzymes in drug metabolism and toxicity (Q36439150) (← links)
- Early immune events in the induction of allergic contact dermatitis (Q36627450) (← links)
- Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology (Q36662875) (← links)
- The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research (Q36667345) (← links)
- Time-dependent CYP inhibition (Q36725214) (← links)
- The evolving role of drug metabolism in drug discovery and development (Q36749461) (← links)
- Influence of structural and functional modifications of selected genotoxic carcinogens on metabolism and mutagenicity - a review (Q36892453) (← links)
- Molecular mechanisms underlying chemical liver injury (Q36991523) (← links)
- Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists. (Q37063800) (← links)
- Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery (Q37150879) (← links)
- Current concepts of mechanisms in drug-induced hepatotoxicity (Q37394799) (← links)
- Weighted feature significance: a simple, interpretable model of compound toxicity based on the statistical enrichment of structural features (Q37420417) (← links)
- Metabolites in safety testing: "MIST" for the clinical pharmacologist (Q37682594) (← links)
- Toxicoproteomics: new paradigms in toxicology research (Q37696489) (← links)
- A review of the electrophilic reaction chemistry involved in covalent DNA binding (Q37781059) (← links)
- Putting bioactivation reactions to work: Targeting antioxidants to mitochondria (Q37802638) (← links)
- Deleterious Effects of Reactive Metabolites (Q37802740) (← links)
- Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development (Q37803316) (← links)
- Overview of strategies for addressing BRIs in drug discovery: Impact on optimization and design (Q37828945) (← links)